title: Biosimilars battle rages on, Amgen fights both sides.
authors.forename: Melanie
authors.initials: M
authors.lastname: Senior
mesh_terms: D059451:Biosimilar Pharmaceuticals / Q000009:adverse effects / Q000191:economics / Q000494:pharmacology*; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D005060:Europe; D006801:Humans; D007878:Legislation as Topic; D040541:Marketing / Q000191:economics; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D059451:Biosimilar Pharmaceuticals